Zai Lab Ltd — Investor Relations & Filings
Filings indexed
639
across all filing types
Latest filing
2026-05-07
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
ZLAB
Zai Lab Ltd. is a global, research-based, commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines. The company focuses on advancing breakthrough therapies to address significant unmet medical needs for patients worldwide. Its strategy combines in-house discovery with strategic global partnerships to build a robust product pipeline. The primary therapeutic areas of focus include oncology, immunology, neuroscience, and infectious diseases. Zai Lab aims to leverage its competencies to positively impact human health by bringing novel treatments from the laboratory to patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Zai Lab Ltd (0001704292) (Filer) | 2026-05-07 | English | |
| 8-K - Zai Lab Ltd (0001704292) (Filer) | 2026-05-07 | English | |
| ARS - Zai Lab Ltd (0001704292) (Filer) | 2026-04-28 | English | |
| DEF 14A - Zai Lab Ltd (0001704292) (Filer) | 2026-04-28 | English | |
| 10-K - ZAI LAB LTD (0001704292) (Filer) | 2026-02-26 | English | |
| 8-K - ZAI LAB LTD (0001704292) (Filer) | 2026-02-26 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 42757486 | 10-Q - Zai Lab Ltd (0001704292) (Filer) | 2026-05-07 | English | ||
| 42764298 | 8-K - Zai Lab Ltd (0001704292) (Filer) | 2026-05-07 | English | ||
| 37970880 | ARS - Zai Lab Ltd (0001704292) (Filer) | 2026-04-28 | English | ||
| 37966968 | DEF 14A - Zai Lab Ltd (0001704292) (Filer) | 2026-04-28 | English | ||
| 32896996 | 10-K - ZAI LAB LTD (0001704292) (Filer) | 2026-02-26 | English | ||
| 32896995 | 8-K - ZAI LAB LTD (0001704292) (Filer) | 2026-02-26 | English | ||
| 31386504 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31386516 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31386453 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31386433 | SCHEDULE 13G/A Filing | 2026-02-10 | English | ||
| 31386440 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 13028552 | Director's Dealing 2026 | 2026-01-02 | English | ||
|
2025
3 filings
| |||||
| 13028554 | Regulatory Filings 2025 | 2025-12-31 | English | ||
| 13028553 | Director's Dealing 2025 | 2025-12-18 | English | ||
| 13028556 | Regulatory Filings 2025 | 2025-12-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Zai Lab Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31208/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31208 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31208 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31208 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31208}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zai Lab Ltd (id: 31208)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.